TAC-T cells

· Triumvira Immunologics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAC-T cells, covering 2025-02-14 to 2025-06-08. Get the full timeline:

Most recent: Clinical Trial Update: TAC T-cells for the Treatment of HER2-positive Solid Tumors [Phase 1, Phase 2]